DaVita Inc. Files 8-K on Security Holder Vote

TL;DR

DaVita shareholders voted on something important on June 6th, filing confirms.

AI Summary

DaVita Inc. filed an 8-K on June 10, 2024, reporting on a matter submitted to a vote of security holders on June 6, 2024. The filing does not disclose the specific details of the vote or the outcome, but it is a procedural filing related to corporate governance.

Why It Matters

This filing indicates a formal process where DaVita Inc. sought or reported on a decision made by its shareholders, which is a standard part of corporate governance and transparency.

Risk Assessment

Risk Level: low — This is a routine procedural filing related to a shareholder vote and does not contain new financial information or significant operational changes.

Key Players & Entities

• DAVITA INC. (company) — Registrant
• 0000927066-24-000115 (filing_id) — Accession Number
• June 6, 2024 (date) — Date of earliest event reported
• June 10, 2024 (date) — Filing Date
• 2000 16th Street Denver, CO 80202 (address) — Principal executive offices

FAQ

From the Filing

0000927066-24-000115.txt : 20240610 0000927066-24-000115.hdr.sgml : 20240610 20240610171409 ACCESSION NUMBER: 0000927066-24-000115 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240606 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 241033759 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva-20240606.htm 8-K dva-20240606 0000927066 false 0000927066 2024-06-06 2024-06-06   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): June 6, 2024     DAVITA INC. (Exact name of registrant as specified in its charter)     DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   2000 16th Street Denver, CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)   ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class:   Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value   DVA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐     Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07.    Submission of Matters to a Vote of Security Holders. On June 6, 2024, DaVita Inc. (the “Company”) held its virtual 2024 Annual Meeting of Stockholders (the “Annual Meeting”). Represented virtually or by proxy at the Annual Meeting were 78,733,171 shares of the Company's common stock, or 89.77% of its outstanding shares of common stock as of April 10, 2024, the record date of the Annua